Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00597714
What this trial is testing

Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
David Rizzieri, MD 264
Testing effectiveness (Phase 2)Ended earlyNCT01627314
What this trial is testing

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

Who this might be right for
Hematologic Malignancies
Fate Therapeutics 62
Testing effectiveness (Phase 2)Looking for participantsNCT06412497
What this trial is testing

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

Who this might be right for
Severe Aplastic AnemiaAcquired Amegakaryocytic ThrombocytopeniaAcquired Pure Red Cell Aplasia+1 more
Masonic Cancer Center, University of Minnesota 60
Testing effectiveness (Phase 2)UnknownNCT03412266
What this trial is testing

RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT

Who this might be right for
Myelodysplastic Syndromes
Peking University People's Hospital 50
Early research (Phase 1)Active Not RecruitingNCT05088356
What this trial is testing

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic MalignanciesAcute Leukemia+3 more
Stanford University 66
Large-scale testing (Phase 3)Ended earlyNCT00150878
What this trial is testing

Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission

Who this might be right for
Acute Myeloid Leukemia
University Hospital Carl Gustav Carus 198
Not applicableUnknownNCT01252784
What this trial is testing

Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic Syndrome
Cooperative Study Group A for Hematology 20
Testing effectiveness (Phase 2)WithdrawnNCT00159055
What this trial is testing

Adoptive Immunotherapy for CMV Disease

Who this might be right for
CMV Disease
Hadassah Medical Organization 20
Large-scale testing (Phase 3)Study completedNCT01597778
What this trial is testing

Double Cord Versus Haploidentical (BMT CTN 1101)

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaBurkitt's Lymphoma+4 more
Medical College of Wisconsin 368
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Study completedNCT03159702
What this trial is testing

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Who this might be right for
Hematological MalignancyMultiple Myeloma
Medical College of Wisconsin 43
Testing effectiveness (Phase 2)Ended earlyNCT00113828
What this trial is testing

Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma+1 more
Massachusetts General Hospital 5
Testing effectiveness (Phase 2)Study completedNCT02277639
What this trial is testing

Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

Who this might be right for
Bone Marrow Failure SyndromesImmunodeficienciesImmune Dysregulation Syndromes
Children's Hospital of Philadelphia 2
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Testing effectiveness (Phase 2)UnknownNCT00930566
What this trial is testing

Extracorporal Photopheresis Pilot Study

Who this might be right for
Hematological Malignancies
Hospices Civils de Lyon 20
Testing effectiveness (Phase 2)Ended earlyNCT01468818
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT00894049
What this trial is testing

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

Who this might be right for
AllograftAllogeneic Cell TransplantaionHematological Malignancy+1 more
Institut Paoli-Calmettes 148
Testing effectiveness (Phase 2)Study completedNCT02224872
What this trial is testing

Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaBone Marrow Failure Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Not applicableStudy completedNCT00186576
What this trial is testing

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersBlood and Marrow Transplant (BMT)+2 more
Stanford University 40
Testing effectiveness (Phase 2)Study completedNCT00425802
What this trial is testing

Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 61
Next Page